Aardvark Therapeutics, Inc. (AARD) KPIs and segments

AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30

$1.33−0.19 (-12.50%)

Close on Nov 13, 2026Market cap $29.11MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Aardvark Therapeutics's business

Coming soon

This tab will track the numbers specific to Aardvark Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?